chr22-31797688-C-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001242896.3(DEPDC5):c.856C>T(p.Arg286*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001242896.3 stop_gained
Scores
Clinical Significance
Conservation
Publications
- epilepsy, familial focal, with variable foci 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Ambry Genetics, Illumina, G2P
- focal epilepsyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- autosomal dominant epilepsy with auditory featuresInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- autosomal dominant nocturnal frontal lobe epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial focal epilepsy with variable fociInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Brugada syndromeInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001242896.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| DEPDC5 | NM_001242896.3 | MANE Select | c.856C>T | p.Arg286* | stop_gained | Exon 13 of 43 | NP_001229825.1 | ||
| DEPDC5 | NM_001364318.2 | c.856C>T | p.Arg286* | stop_gained | Exon 13 of 43 | NP_001351247.1 | |||
| DEPDC5 | NM_001136029.4 | c.856C>T | p.Arg286* | stop_gained | Exon 13 of 43 | NP_001129501.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| DEPDC5 | ENST00000651528.2 | MANE Select | c.856C>T | p.Arg286* | stop_gained | Exon 13 of 43 | ENSP00000498382.1 | ||
| DEPDC5 | ENST00000382112.8 | TSL:1 | c.856C>T | p.Arg286* | stop_gained | Exon 13 of 43 | ENSP00000371546.4 | ||
| DEPDC5 | ENST00000433147.2 | TSL:1 | c.772C>T | p.Arg258* | stop_gained | Exon 12 of 42 | ENSP00000410544.2 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Epilepsy, familial focal, with variable foci 1 Pathogenic:1Other:1
Familial focal epilepsy with variable foci Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg286*) in the DEPDC5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DEPDC5 are known to be pathogenic (PMID: 23542697, 23542701). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with familial focal epilepsy with variable foci (PMID: 26704558). ClinVar contains an entry for this variant (Variation ID: 2580197). For these reasons, this variant has been classified as Pathogenic.
not provided Pathogenic:1
Not observed at significant frequency in large population cohorts (gnomAD); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 26704558, 29708508, 31440721, 30093711, 32712949)
Epilepsy, familial focal, with variable foci 1;C5882690:Developmental and epileptic encephalopathy 111 Pathogenic:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at